NIH funding cuts delayed a promising childhood brain cancer trial. Patients lost time they didn't have.

A clinical trial for childhood brain cancer was delayed due to federal research funding constraints, according to reporting on the study. DIPG, or diffuse intrinsic pontine glioma, is a brain tumor affecting children with limited treatment options available.

Next story